Hangzhou Minsheng Healthcare Co Ltd - Asset Resilience Ratio
Hangzhou Minsheng Healthcare Co Ltd (301507) has an Asset Resilience Ratio of 26.41% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hangzhou Minsheng Healthcare Co Ltd (301507) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Hangzhou Minsheng Healthcare Co Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Hangzhou Minsheng Healthcare Co Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Hangzhou Minsheng Healthcare Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Hangzhou Minsheng Healthcare Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥552.18 Million | 26.41% |
| Total Liquid Assets | CN¥552.18 Million | 26.41% |
Asset Resilience Insights
- Very High Liquidity: Hangzhou Minsheng Healthcare Co Ltd maintains exceptional liquid asset reserves at 26.41% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Hangzhou Minsheng Healthcare Co Ltd Industry Peers by Asset Resilience Ratio
Compare Hangzhou Minsheng Healthcare Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AstraZeneca PLC
F:ZEGA |
Drug Manufacturers - General | 0.03% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 0.08% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.48% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 5.48% |
|
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096 |
Drug Manufacturers - General | 1.58% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
Annual Asset Resilience Ratio for Hangzhou Minsheng Healthcare Co Ltd (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Hangzhou Minsheng Healthcare Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 26.88% | CN¥542.28 Million ≈ $79.35 Million |
CN¥2.02 Billion ≈ $295.16 Million |
-1.56pp |
| 2024-12-31 | 28.44% | CN¥496.20 Million ≈ $72.61 Million |
CN¥1.74 Billion ≈ $255.29 Million |
+9.22pp |
| 2023-12-31 | 19.22% | CN¥316.70 Million ≈ $46.34 Million |
CN¥1.65 Billion ≈ $241.13 Million |
+11.62pp |
| 2022-12-31 | 7.60% | CN¥58.14 Million ≈ $8.51 Million |
CN¥765.29 Million ≈ $111.99 Million |
-26.64pp |
| 2021-12-31 | 34.23% | CN¥233.30 Million ≈ $34.14 Million |
CN¥681.49 Million ≈ $99.72 Million |
-- |
About Hangzhou Minsheng Healthcare Co Ltd
Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and health foods in China. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin,… Read more